Quanticate
Private Company
Total funding raised: $75M
Overview
Quanticate is a specialized, service-based biometrics CRO that provides critical statistical, programming, and data management expertise to accelerate clinical trials for pharma and biotech clients. It differentiates itself through deep biometrics specialization, a focus on functional service provision (FSP) and fixed-cost projects, and the integration of AI and automation tools like its QSummarise platform to enhance efficiency. With experience across over 80 therapeutic indications and a global operational footprint, the company positions itself as a trusted partner for complex and rescue studies, from protocol design through to regulatory submission support.
Technology Platform
AI and automation platform for clinical data, featuring QSummarise for automated SDTM dataset creation and CDISC mapping. Integrates AI throughout statistical, programming, and data management processes.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Competes against large, full-service CROs (e.g., IQVIA, Parexel) and other specialized biometrics/service providers. Differentiation is based on deep biometrics focus, flexible resourcing models, and proprietary AI/automation tools designed to improve data submission speed and quality.